This MedLibrary.org supplementary page on Gallbladder cancer is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Gallbladder cancer Classification and external resources |
|
| ICD-10 | C23.-C24. |
|---|---|
| ICD-9 | 156 |
| MeSH | D005706 |
Gallbladder cancer is a relatively uncommon cancer. If it is diagnosed early enough, it can be cured by removing the gallbladder. Most often it is found after symptoms such as abdominal pain and jaundice occur, and it has spread to other organs such as the liver.
It is a rare cancer that is still being studied and thought to be related to gallstones building up, which also can lead to calcification of the gallbladder, a condition known as Porcelain gallbladder. Porcelain gallbladder is also rare. Some studies indicate that people with porcelain gallbladder have a high risk of developing gallbladder cancer, but other studies question this. The outlook is poor for recovery if the cancer is found after symptoms have started to occur.
Contents |
Risk factors
- Gender: More women than men are affected by gallbladder cancer, mostly commonly between the ages of 50 and 60.
- Obesity increases the risk for gallbladder cancer. It is most common in indigenous peoples of the Americas.
- Primary carcinoma is linked to chronic cholecystitis and cholelithiasis.
- Alcohol: "…alcohol drinking is a risk factor of gallbladder cancer…"[1] [2]
Signs and Symptoms
- Steady pain in the upper right abdomen for around 2 months.
- Diarrhea
- Burping
- Weakness
- Loss of appetite
- Weight loss
- Vomiting
- Infection, leading to peritonitis, gangrene, perforation, and or liver abscess
- Jaundice, due to obstruction
Early symptoms mimic gallbladder inflammation and gallstones, which must be excluded as the cause. Later, the symptoms may be that of biliary obstruction.
Disease Course
Most tumors are adenocarcinomas, with a small percent being squamous cell carcinomas. The cancer commonly spreads to the liver, pancreas, stomach,and duodenum.
Diagnosis
Early diagnosis is not generally possible. People at high risk, such as women or Native Americans with frequent gallstones, are evaluated closely. Endoscopic ultrasound, transabdominal ultrasound, CT scan, MRI, and MR cholangiopancreatography can be used to diagnose.
Treatment
The most common and most effective treatment is surgical removal of the gallbladder (cholecystectomy) with lymph node dissection. However, with gallbladder cancer's extremely poor prognosis, most will die by one year following the surgery. If surgery is not possible, endoscopic stenting of the biliary tree can reduce jaundice. Chemotherapy and radiation may also be used with surgery. Mutant Adenovirus based treatment is under investigation by several researcher [5][6] and a company has even got license to use a mutant of Adenovirus (Onyx-15) to cure cancer.
Additional images
References
- ^ Ji, J; Hemminki K (2005 Sep). "Variation in the risk for liver and gallbladder cancers in socioeconomic and occupational groups in Sweden with etiological implications". Int Arch Occup Environ Health 78 (8): 641–9. PMID 16001211. Retrieved on 2007-05-28.
- ^ Ji J, Couto E, Hemminki K. Incidence differences for gallbladder cancer between occupational groups suggest an etiological role for alcohol Int J Cancer 2005 Sep 1;116(3):492-3.
- 3. Lewis, S.M., Heitkemper, M.M., & Dirksen, S.R. Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 6th ed. St. Louis: Mosby, 2004.
- 4. McCance,K., & Huether, S. Pathophysiology: The Biologic Basis for Disease in Adults & Children, 4th ed. St. Louis: Mosby, 2002.
- 5.Toshihiro Tanaka, Hideo Shimura, Takamitsu Sasaki, Kou Narumi, Makoto Maemondo, Toshihiro Nukiwa, Kunio Matsumoto, Toshikazu Nakamura and Seiyo Ikeda1, Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model, Cancer Gene Therapy (2004) 11, 431–440.
- 6. Kuniaki Fukuda, Masato Abei2, Hideyo Ugai, Emiko Seo, Mariko Wakayama, Takehide Murata, Takeshi Todoroki, Naomi Tanaka, Hirofumi Hamada and Kazunari K. Yokoyama, E1A, E1B Double-restricted Adenovirus for Oncolytic Gene Therapy of Gallbladder Cancer, Cancer Research 63, 4434-4440, August 1, 2003.
External links
|
||||||||||||||||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 2 September 2008, at 07:19.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Gallbladder cancer".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.
